Researchers have found that critical and severe COVID-19 patients have a highly impaired interferon response, which encourages a persistent blood viral load and heightened inflammatory response. This phenotype is now said to be associated with a poor prognosis.
Existing antimicrobial therapies are failing us. New chemical antimicrobials have not been forthcoming. Heather Louise O’Donoghue asks: How do you solve a problem like antimicrobial resistance?
Researchers from the University of California have discovered that inhibition of the PTB gene in mice converts neural support cells into dopamine-producing neurones.